University of Arkansas
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Arkansas sits in the top decile of US sponsors by registered trial count (#113 of 15,742 sponsors by registered trial count).
University of Arkansas: 318 sponsored US clinical trials, 37 recruiting.
University of Arkansas sponsors 318 registered US clinical trials on ClinicalTrials.gov, 37 of them currently recruiting, and 202 completed. 17 of these trials are in Phase 3-4 (later-stage) and 102 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Myeloma, with 15 trials.
Top-decile sponsor footprint
University of Arkansas ranks in the top decile of sponsors by registered trial count (#113 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
202 of 262 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
318 total, page 2 of 7
UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma
NCT00734877
Axillary Reverse Mapping
NCT00572481
UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
NCT00572169
Quit and Screen Project
NCT06350643
Essential Amino Acid Supplementation in Adult Spinal Deformity Patients
NCT07341399
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
NCT07029776
Occupational Impacts of Resistance Training in Older Adults
NCT07323212
Behavioral Pharmacology of Cannabis in Older Adults
NCT06055309
Nurse-led Mind-body Intervention on Sexual Health for Breast Cancer Survivors
NCT06307470
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework
NCT06461416
Characterization of Pre-Term Neonatal Skin
NCT05127044
Mindfulness in Hidradenitis Suppurativa
NCT06123429
Universal Basic Income and Structural Racism in the US South
NCT05778578
Traditional Dorsal Digital Block Vs Volar Subcutaneous Digital Block
NCT05280704
Effects of Beef Consumption on Skeletal Muscle Protein Homeostasis and Inflammatory Factors in Pre- and Postmenopausal Females
NCT05714462
Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
NCT05912400
Impact of Time Restricted Feeding on Daily Protein Requirements
NCT05610644
A Pragmatic Approach to CKD Patient Education
NCT05138419
The Impact of Hearing Loss Severity on Balance Intervention Outcomes
NCT05681078
Comparison of Health Care Delivery Methods in Parkinson's Disease
NCT05725772
Product Testing of the FaceView Mask™: Usability Survey
NCT04854694
The Good Food Rx: Food-as-medicine Program
NCT05541458
Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study)
NCT05125471
Auditory Processing in Spanish-English Bilinguals: Is Performance Better When Tested in Spanish or English?
NCT05452486
Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer
NCT05235750
Role of the Protein Matrix in the Anabolic Response to a Ground Beef Patty as Opposed to the Impossible (Vegi-) Burger
NCT05197140
A Pilot Project for Multifidus Muscle Evaluation in Patients With Multiple Sclerosis
NCT05427045
Family Model Diabetes Self-Management Education in Faith Based Organizations
NCT04256486
Blood Flow Restriction Training in ACL Surgery
NCT05245864
Nutritional Biomarkers of Sarcopenia
NCT05117112
Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA
NCT04305158
Implementing Cabenuva in Arkansas HIV Programs
NCT05096949
Impact of a POPOP on Preoperative Health, Eligibility, and Clinical & Patient-Reported Outcomes in TJA
NCT04910048
Evaluation of a Comprehensive School Nutrition Enrichment Intervention (CSNEI) in Rural School Districts
NCT05507866
Expanding Knowledge About and Evaluating Services for Incarcerated Pregnant and Postpartum Women in Arkansas
NCT04421235
Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers
NCT04850313
Text Message Intervention for Alcohol Use and Sexual Violence in College Students
NCT05065918
Home Food Delivery for Diabetes Management in Patients of Rural Clinics
NCT04876053
Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane
NCT03930680
Delivering Health: Addressing Diabetes and Food Insecurity
NCT04831216
Pediatric Language and Memory Mapping in Refractory Epilepsy Using Magnetoencephalography
NCT04888637
Neurodevelopmental Outcomes in Craniosynostosis Repair
NCT04072783
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
NCT04493333
Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics
NCT04830514
How do You Take Your Coffee Before Anesthesia
NCT04786691
Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation
NCT04960592
Comparative Effectiveness of Family DSMES and Standard DSMES Among Diverse Populations
NCT04334109
Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD
NCT04274192
Innovative Care of Older Adults With Chronic Heart Failure: A Comparative Effectiveness Clinical Trial (I-COACH)
NCT04304833
Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes
NCT04612400
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 62 |
| Phase 3 | 13 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the University of Arkansas pipeline
37 recruiting of 318 indexed (12% open); 202 completed (64%).
Phase mix: 17 late (III/IV) vs 102 early (I/II) (early-phase heavy).
Top condition: Multiple Myeloma (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Arkansas: open-pipeline peers nationwide
Peers matched on 318 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
University of Arkansas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 318 trials (± recruiting share)
- Rush University Medical Center · 320 trials · 17% recruiting
- Jonsson Comprehensive Cancer Center · 321 trials · 19% recruiting
- Allergan · 314 trials · 0% recruiting
- Celgene · 308 trials · 4% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Jazz Pharmaceuticals · 12% recruiting · 128 trials
- Abbott Diabetes Care · 12% recruiting · 26 trials
- Medtronic Vascular · 12% recruiting · 26 trials
- Midwest Center for Metabolic and Cardiovascular Research · 12% recruiting · 26 trials
Related
What to do with this University of Arkansas page
318 registered trials is a research-attention snapshot, not an endorsement of University of Arkansas or any single study.
- 37 of University of Arkansas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Myeloma is the condition University of Arkansas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Myeloma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Arkansas pipeline card: 318 registered trials from official public datasets.Report a data error.